RSS

Mergers & acquisitions (M&A)

This year will be big for Duchenne muscular dystrophy (DMD) as interest in treatments is on the rise and deal activity is increasing, reported data and analytics company, GlobalData. more

Analysis

According to Catalyst Corporate Finance, UK service-based pharma businesses involved in ‘smart’ areas of the market are experiencing heightened interest from domestic and international acquirers. more

Analysis

According to data from Catalyst Corporate Finance, the UK business of Alantra, 2017 has seen M&A and investment activity in the UK Healthcare sector remain high. Here, Justin Crowther (partner) identifies five significant deals of the year more

News

In a press statement from the European Commission, it has been announced that the proposed acquisition of Huber Silica by Evonik has been approved, subject to divestment of some of both companies’ activities relating to precipitated silica. more

News

Despite a downturn in M&A activity during the latter part of 2016, prospects are on the rise. In this article, we analyse what deals are on the table, coming to the table and those that are still in the kitchen waiting to be plated up! more

Opinion

Alexandre Alain, life science product manager at compliance management company EtQ writes about mergers and acquisitions in the life sciences sector. more

News

Capsule specialist Capsugel is acquired by major pharma player Lonza, and investment firm KKR. more

News

Life science mergers and acquisitions are on the rise, but risk management is crucial if M&A deals are to add genuine business value more

News

It seems we’re never far from a merger or acquisition in the pharmaceutical sector more

Opinion

PFIZERALLERGAN.jpg

Rob Wilson / Shutterstock.com

Big pharma player Pfizer has inked its long-rumoured deal to buy botox maker Allergan, in what the BBC describes as “the biggest pharmaceuticals deal in history” more

News

With hostile takeovers on the rise, Mike Straw, CEO of Achieve Breakthrough, looks at how both sides can adapt and succeed more

Opinion

Mergers & acquisitions – it’s all about collaboration, says Mike Straw, Achieve Breakthrough. He argues that deals are all about people as well as the numbers – and it’s the collaboration that will make a deal truly work. more

Opinion

Patheon explains the importance of mergers and acquisitions as the company strengthens its position in the sector. more

Opinion

China-based biotechnology company 3SBio has acquired the entire share capital of Italian group Sirton Pharmaceuticals. more

News

Be it dwindling drug pipelines or changes from the Affordable Care Act, mergers and acquisitions in the healthcare and life sciences industries are expected to continue unabated in 2015. more

News

Bayer has completed the acquisition of the consumer care business of US pharma group Merck & Co. more

News

Consort Medical has announced that it has agreed terms to acquire Aesica Pharmaceuticals for £230 million. more

News

Mergers - how do we benefit?

Stephen Archer of Spring Partnerships looks back on months of M&A buzz in the pharma community, and examines whether the industry really stands to benefit from corporate buyouts. more

25 Sep 2014 12:32 Guest Blogs

Endo International’s bid to acquire Auxilium Pharmaceuticals last week has been rejected by the latter, according to news agency Reuters. Auxilium is said to have made the statement that the bid “significantly undervalues” the company. more

News

The value so far in 2014 is already higher than the annual value for the last 8 years. more